Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/03331024211036665 http://scihub22266oqcxt.onion/10.1177/03331024211036665 34407648!8793291!34407648     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34407648&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Cephalalgia 2022 ; 42 (2): 176-180 Nephropedia Template TP {{tp|p=34407648|t=2022. Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19 |pdf=|usr=}}{{34407648}} gab.com Text Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19 JO: Cephalalgia http://www.kidney.de/pget.php?&tw=1&pmid=34407648 #FOAvip Clinical publications show consistently that headache is a common symptom in the coronavirus disease of 2019 (COVID-19). Several studies specifically investigated headache symptomatology and associated features in patients with COVID-19. The headache is frequently debilitating with manifold characters including migraine-like characteristics. Studies suggested that COVID-19 patients with headache vs. those without headache are more likely to have anosmia. We present a pathophysiological hypothesis which may explain this phenomenon, discuss current hypotheses about how the coronavirus SARS-CoV-2 enters the central nervous system and suggest that activation of the trigeminal nerve may contribute to both headache and anosmia in COVID-19. Twit Text FOAVip Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19 ????Cephalalgia http://www.kidney.de/pget.php?&tw=1&pmid=34407648 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34407648 #FOAvip English Wikipedia <ref>{{Cite pmid|34407648}}</ref> Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19 #MMPMID34407648 Messlinger K; Neuhuber W; May A Cephalalgia 2022[Feb]; 42 (2): 176-180 PMID34407648show ga Clinical publications show consistently that headache is a common symptom in the coronavirus disease of 2019 (COVID-19). Several studies specifically investigated headache symptomatology and associated features in patients with COVID-19. The headache is frequently debilitating with manifold characters including migraine-like characteristics. Studies suggested that COVID-19 patients with headache vs. those without headache are more likely to have anosmia. We present a pathophysiological hypothesis which may explain this phenomenon, discuss current hypotheses about how the coronavirus SARS-CoV-2 enters the central nervous system and suggest that activation of the trigeminal nerve may contribute to both headache and anosmia in COVID-19. |*COVID-19[MESH] |*Migraine Disorders[MESH] |*Olfaction Disorders[MESH] |Anosmia[MESH] |Headache/etiology[MESH] |Humans[MESH]Activation of the trigeminal system as a likely target of SARS-CoV-2 m(epmc).pdf DeepDyve Pubget Overpricing